Dupont N, Nascimbeni A C, Morel E, Codogno P
Institut Necker-Enfant Malades (INEM), INSERM, Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
Institut Necker-Enfant Malades (INEM), INSERM, Université Paris Descartes-Sorbonne Paris Cité, Paris, France.
Int Rev Cell Mol Biol. 2017;328:1-23. doi: 10.1016/bs.ircmb.2016.08.001. Epub 2016 Sep 28.
Macroautophagy is a lysosomal catabolic process that maintains the homeostasis of eukaryotic cells, tissues, and organisms. Macroautophagy plays important physiological roles during development and aging processes and also contributes to immune responses. The process of macroautophagy is compromised in diseases, such as cancer, neurodegenerative disorders, and diabetes. The autophagosome, the double-membrane-bound organelle that sequesters cytoplasmic material to initiate macroautophagy, is formed by the hierarchical recruitment of about 15 autophagy-related (ATG) proteins and associated proteins, such as DFCP1, AMBRA1, the class III phosphatidyl-inositol 3-kinase VPS34, and p150/VPS15. Evidence suggests that in addition to the canonical pathway, noncanonical pathways that do not require the entire repertoire of ATGs can also result in formation of autophagosomes. Here we will discuss recent discoveries concerning the molecular regulation of these noncanonical forms of macroautophagy and their potential roles in cellular responses to stressful situations.
巨自噬是一种溶酶体分解代谢过程,可维持真核细胞、组织和生物体的稳态。巨自噬在发育和衰老过程中发挥重要的生理作用,也有助于免疫反应。在癌症、神经退行性疾病和糖尿病等疾病中,巨自噬过程会受到损害。自噬体是一种双膜结合细胞器,它隔离细胞质物质以启动巨自噬,由大约15种自噬相关(ATG)蛋白和相关蛋白(如DFCP1、AMBRA1、III类磷脂酰肌醇3激酶VPS34和p150/VPS15)的分级募集形成。有证据表明,除了经典途径外,不需要完整ATG库的非经典途径也可导致自噬体的形成。在此,我们将讨论有关这些非经典形式巨自噬的分子调控及其在细胞对应激情况反应中的潜在作用的最新发现。